Last deal

$6.02M
Local Amount - AUD 7.75M

Amount

Venture - Series Unknown

Stage

10.04.2018

Date

3

all rounds

$20.82M

Total amount

date founded

Financing round

General

About Company
Global Kinetics Corporation commercialises technology that records and reports movement symptoms of neurological disease.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

GKC's algorithm-based system, Parkinson's KinetiGraph® (PKG®), provides continuous, objective, ambulatory assessment of movement disorder symptoms, and has been clinically validated and cleared by regulatory authorities.. The PKG® system is being used in clinics across the U.S., Europe and Asia Pacific, and GKC is pursuing partnerships with major pharmaceutical and medical technology companies to measure the efficacy of new and advanced therapies for Parkinson's disease.
Contacts
Similar Companies
1000
Adamant Health

Adamant Health

A new technology to analyse Parkinson's disease symptoms is being developed by Adamant Health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Medical

Location

Kuopio, Finland

total rounds

2

total raised

$2.11M
PAL Technologies

PAL Technologies

PAL Technologies provides clinical tools for measuring free-living, everyday activities and behavior.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology
SmartCatch

SmartCatch

SmartCatch develops liquid biopsy technology to fight cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Toulouse, France

total rounds

1

total raised

$2.63M
miR Scientific

miR Scientific

MiR Scientific is a healthcare company revolutionizing cancer management with highly accurate cancer detection and monitoring..

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Rensselaer, NY 12144, USA

Financials

Funding Rounds
3
3

Number of Funding Rounds

$20.82M

Money Raised

Their latest funding was raised on 10.04.2018. Their latest investor Brandon Capital Partners. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
10.04.2018
1
$6.02M
Local Amount - AUD 7.75M
19.05.2015
$1.5M
Brandon Capital Partners

Brandon Capital Partners

Brandon Capital Partners is an Australian fund management business specializing in life science investments.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Dandenong Rd, Melbourne VIC, Australia

count Of Investments

60

count Of Exists

3
Brandon Capital Partners

Brandon Capital Partners

Brandon Capital Partners is an Australian fund management business specializing in life science investments.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Dandenong Rd, Melbourne VIC, Australia

count Of Investments

60

count Of Exists

3
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Venture - Series Unknown
Brandon Capital Partners

Brandon Capital Partners

Brandon Capital Partners is an Australian fund management business specializing in life science investments.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Dandenong Rd, Melbourne VIC, Australia

count Of Investments

60

count Of Exists

3

People

Founders
1
Malcolm Horne
Malcolm Horne

Malcolm Horne

Professor Malcolm Horne is a co-founder of GKC and co-developed the company’s lead product the PKG™. Concurrently, Professor Horne maintains roles at the Florey Institute of Neuroscience and Mental Health, as Professor of Neuroscience at University of Melbourne and manages a clinical practice in movement disorders at St Vincent’s Hospital, Melbourne. Previously, Professor Horne held key roles in brain disorder related medical associations including the President of the Parkinson’s Disease Association (1991-1993) and Deputy Chairman of the Australian Brain Foundation (1994-1997). Professors Horne’s field of research includes various aspects of Parkinson’s Disease. As a recognised leader in Parkinson’s clinical practice and research, Professor Horne has over 200 publications.

current job

Global Kinetics Corporation
Global Kinetics Corporation

organization founded

1

Malcolm Horne

Employee Profiles
4
Kathryn Meintsma

Kathryn Meintsma

Contract General Counsel and Compliance Officer

Brooke Ren

Brooke Ren

Chief Operations Officer, General Manager of China Business Unit

Malcolm Horne

Malcolm Horne

Co-Founder

ANDREW MAXWELL

ANDREW MAXWELL

CEO

Activity

Recent News
0